newsfilter
← Latest News
PR Newswire·

SUEWALLST, LLP: INSTITUTIONAL RGNX HOLDERS FACE PORTFOLIO LOSSES FROM GENE THERAPY FRAUD

Institutional investors holding positions in REGENXBIO, Inc. (NASDAQ: RGNX) during the period between February 9, 2022 and January 27, 2026 may wish...